FDA — authorised 15 March 1949
- Marketing authorisation holder: RECORDATI RARE
- Status: approved
🇺🇸 Valchlor in United States
FDA authorised Valchlor on 15 March 1949
Marketing authorisations
FDA — authorised 9 July 2014
- Application: NDA202317
- Marketing authorisation holder: HELSINN
- Indication: Labeling
- Status: approved
Valchlor in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Valchlor approved in United States?
Yes. FDA authorised it on 15 March 1949; FDA authorised it on 9 July 2014.
Who is the marketing authorisation holder for Valchlor in United States?
RECORDATI RARE holds the US marketing authorisation.